Schlumberger MJ - Search Results

1

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Schlumberger MJ, Elisei R, Bastholt L, Wirth LJ, Martins RG, Locati LD, Jarzab B, Pacini F, Daumerie C, Droz JP, Eschenberg MJ, Sun YN, Juan T, Stepan DE, Sherman SI. Schlumberger MJ, et al. J Clin Oncol. 2009 Aug 10;27(23):3794-801. doi: 10.1200/JCO.2008.18.7815. Epub 2009 Jun 29. J Clin Oncol. 2009. PMID: 19564535 Clinical Trial.

2

TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.

Mechelany C, Schlumberger M, Challeton C, Comoy E, Parmentier C. Mechelany C, et al. Clin Endocrinol (Oxf). 1991 Aug;35(2):123-8. doi: 10.1111/j.1365-2265.1991.tb03509.x. Clin Endocrinol (Oxf). 1991. PMID: 1934526

3

Combination therapy for anaplastic giant cell thyroid carcinoma.

Schlumberger M, Parmentier C, Delisle MJ, Couette JE, Droz JP, Sarrazin D. Schlumberger M, et al. Cancer. 1991 Feb 1;67(3):564-6. doi: 10.1002/1097-0142(19910201)67:3<564::aid-cncr2820670306>3.0.co;2-e. Cancer. 1991. PMID: 1985750 Clinical Trial.

4

5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.

Schlumberger M, Brugieres L, Gicquel C, Travagli JP, Droz JP, Parmentier C. Schlumberger M, et al. Cancer. 1991 Jun 15;67(12):2997-3000. doi: 10.1002/1097-0142(19910615)67:12<2997::aid-cncr2820671211>3.0.co;2-#. Cancer. 1991. PMID: 2044046

5

Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy.

Droz JP, Schlumberger M, Rougier P, Ghosn M, Gardet P, Parmentier C. Droz JP, et al. Tumori. 1990 Oct 31;76(5):480-3. doi: 10.1177/030089169007600513. Tumori. 1990. PMID: 2256195 Clinical Trial.

6

Phase II evaluation of mitoxantrone in advanced non anaplastic thyroid cancer.

Schlumberger M, Parmentier C. Schlumberger M, et al. Bull Cancer. 1989;76(4):403-6. Bull Cancer. 1989. PMID: 2752182

7

5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma.

Schlumberger M, Ostronoff M, Bellaiche M, Rougier P, Droz JP, Parmentier C. Schlumberger M, et al. Cancer. 1988 Apr 15;61(8):1492-4. doi: 10.1002/1097-0142(19880415)61:8<1492::aid-cncr2820610803>3.0.co;2-1. Cancer. 1988. PMID: 3349416

8

[Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].

Droz JP, Rougier P, Goddefroy V, Schlumberger M, Gardet P, Parmentier C. Droz JP, et al. Bull Cancer. 1984;71(3):195-9. Bull Cancer. 1984. PMID: 6541515 French.

9

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).

Schlumberger M, Abdelmoumene N, Delisle MJ, Couette JE. Schlumberger M, et al. Br J Cancer. 1995 Feb;71(2):363-5. doi: 10.1038/bjc.1995.73. Br J Cancer. 1995. PMID: 7530987 Free PMC article. Clinical Trial.

10

Cushing's syndrome in medullary thyroid carcinoma.

Mure A, Gicquel C, Abdelmoumene N, Tenenbaum F, Francese C, Travagli JP, Gardet P, Schlumberger M. Mure A, et al. J Endocrinol Invest. 1995 Mar;18(3):180-5. doi: 10.1007/BF03347800. J Endocrinol Invest. 1995. PMID: 7615903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

624 results

Search Page